Investing Profile

David Bonita

InvestorVC

General Partner at OrbiMed

orbimed.comNew York, New York

‌

‌

‌

Your Intro Paths to David Bonita

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find David Bonita on

cb

Current Investing Position

OrbiMed General Partner

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

25

Current Fund Size

$18B

David Bonita is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Health IT (Series A)Pharmaceuticals (Series A)New York City Health & Hospital Services (Series A)Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

David Bonita's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Magenta Medical	Series UnknownJul 2024$110M Series UnknownMay 2023$55M	$160M
Rampart Bioscience	Series AOct 2023$85M	$85M
Co-investors: Dmitrij Hristodorov (Forbion)
Congruence Therapeutics	Series AMar 2023$15M Series AFeb 2022$50M	$65M
Co-investors: Michelle Scarborough (BDC Venture Capital), Nancy Harrison (Amplitude VC)
Tricida	Post Ipo EquityNov 2021$42M Series DNov 2017$58M Series CJul 2016$55M Series BMar 2015$30M Series ASep 2014$10M	$320M
Co-investors: Scott Bluestein (Hercules Capital)
Repare Therapeutics	Series BSep 2019$83M	$150M
Co-investors: Jérôme Nycz (BDC Venture Capital)
Imara	Series BMar 2019$63M	$63M
Co-investors: Mark Chin (Arix Bioscience), Joseph Anderson (Soffinova Partners)
Third Harmonic Bio	Series AJan 2019$50M	$50M
Co-investors: Jason Rhodes (Atlas Venture), Michael Gladstone (Atlas Venture)
Sublimity Therapeutics	Series UnknownMay 2018$64M	$64M

Investors who invest with David Bonita

Alexandria Huynh

Charles Steinman